11.07.2015 Views

Guidelines on the Prevention and Control of Tuberculosis in Ireland

Guidelines on the Prevention and Control of Tuberculosis in Ireland

Guidelines on the Prevention and Control of Tuberculosis in Ireland

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<str<strong>on</strong>g>Guidel<strong>in</strong>es</str<strong>on</strong>g> <strong>on</strong> <strong>the</strong> Preventi<strong>on</strong> <strong>and</strong> C<strong>on</strong>trol <strong>of</strong> <strong>Tuberculosis</strong> <strong>in</strong> Irel<strong>and</strong> 2010HSE/HPSCthan 100 times more expensive than treatment <strong>of</strong> drug susceptible TB) <strong>and</strong> is also more toxic to patients.Recent f<strong>in</strong>d<strong>in</strong>gs from a survey c<strong>on</strong>ducted by WHO <strong>and</strong> <strong>the</strong> US Centers for Disease C<strong>on</strong>trol <strong>and</strong> Preventi<strong>on</strong>(CDC) <strong>on</strong> data from 2000-2004 found that XDR-TB has been identified <strong>in</strong> all regi<strong>on</strong>s <strong>of</strong> <strong>the</strong> world butwas most frequent <strong>in</strong> <strong>the</strong> former Soviet Uni<strong>on</strong> <strong>and</strong> <strong>in</strong> Asia. 7 A recent outbreak <strong>of</strong> XDR-TB <strong>in</strong> HIV-<strong>in</strong>fected<strong>in</strong>dividuals <strong>in</strong> South Africa highlighted a worry<strong>in</strong>g situati<strong>on</strong> whereby 52 <strong>of</strong> 53 XDR-TB patients died with<strong>in</strong> amedian <strong>of</strong> 16 days. 81.2 <strong>Tuberculosis</strong> <strong>in</strong> EuropeIn European countries, <strong>the</strong> decl<strong>in</strong>e <strong>of</strong> TB <strong>in</strong> <strong>the</strong> latter half <strong>of</strong> <strong>the</strong> twentieth century was accelerated by acomb<strong>in</strong>ati<strong>on</strong> <strong>of</strong> improved socioec<strong>on</strong>omic c<strong>on</strong>diti<strong>on</strong>s such as better hous<strong>in</strong>g <strong>and</strong> reducti<strong>on</strong> <strong>of</strong> overcrowd<strong>in</strong>g<strong>and</strong> biological factors e.g. improved nutriti<strong>on</strong>, advent <strong>of</strong> chemo<strong>the</strong>rapeutic drugs, BCG immunisati<strong>on</strong>programmes. 9 However, <strong>in</strong> <strong>the</strong> last decade overall rates <strong>in</strong> <strong>the</strong> WHO European regi<strong>on</strong> began to <strong>in</strong>creasesteadily from 28 notificati<strong>on</strong>s per 100,000 populati<strong>on</strong> <strong>in</strong> 1994 to 54 notificati<strong>on</strong>s per 100,000 populati<strong>on</strong><strong>in</strong> 2007. 10 Disparities <strong>in</strong> rates between Western <strong>and</strong> Eastern European countries are apparent <strong>and</strong> havediverged fur<strong>the</strong>r <strong>in</strong> recent years. The <strong>in</strong>cidence <strong>of</strong> disease <strong>in</strong> <strong>the</strong> Eastern European regi<strong>on</strong> (compris<strong>in</strong>gmostly <strong>of</strong> states <strong>of</strong> <strong>the</strong> former Soviet Uni<strong>on</strong>) c<strong>on</strong>t<strong>in</strong>ues to <strong>in</strong>crease annually <strong>and</strong> <strong>in</strong> 2007 rates <strong>in</strong> excess <strong>of</strong>131 cases per 100,000 populati<strong>on</strong> were reported. Former Soviet Uni<strong>on</strong> countries have <strong>the</strong> greatest burden<strong>of</strong> disease <strong>and</strong> <strong>the</strong> highest rates <strong>of</strong> multidrug-resistance <strong>and</strong> mortality rates rang<strong>in</strong>g from 3.0 to 22.3 deathsper 100,000 populati<strong>on</strong>. This regi<strong>on</strong> rema<strong>in</strong>s a priority for TB c<strong>on</strong>trol. 10The Western European regi<strong>on</strong> (European Uni<strong>on</strong> <strong>and</strong> Western European countries) reported a rate <strong>of</strong> 17cases per 100,000 populati<strong>on</strong> <strong>in</strong> 2007. This regi<strong>on</strong> experienced a steady decrease <strong>in</strong> overall TB <strong>in</strong>cidencefor a number <strong>of</strong> decades, briefly reversed <strong>in</strong> certa<strong>in</strong> countries <strong>in</strong> <strong>the</strong> early 1990s. 11 This pattern was also firstobserved <strong>in</strong> <strong>the</strong> United States <strong>of</strong> America dur<strong>in</strong>g <strong>the</strong> 1980s <strong>and</strong> early 1990s due <strong>in</strong> part to <strong>the</strong> impact <strong>of</strong>HIV but also due to <strong>the</strong> problems <strong>of</strong> homelessness, drug abuse, immigrati<strong>on</strong> from high <strong>in</strong>cidence countries<strong>and</strong> deteriorati<strong>on</strong> <strong>in</strong> liv<strong>in</strong>g c<strong>on</strong>diti<strong>on</strong>s <strong>and</strong> health care delivery to <strong>the</strong> poor. 12 A c<strong>on</strong>certed effort to c<strong>on</strong>trolTB <strong>in</strong> <strong>the</strong> US resulted <strong>in</strong> a 45% reducti<strong>on</strong> <strong>in</strong> cases <strong>and</strong> halved <strong>the</strong> <strong>in</strong>cidence rate to 5 cases per 100,000populati<strong>on</strong> between 1992 <strong>and</strong> 2002.In low-<strong>in</strong>cidence European countries, specific challenges to TB c<strong>on</strong>trol have emerged as a result <strong>of</strong> thisshift from high to low <strong>in</strong>cidence. 13 These <strong>in</strong>clude a decl<strong>in</strong><strong>in</strong>g <strong>in</strong>cidence <strong>in</strong> native populati<strong>on</strong>s, <strong>the</strong> <strong>in</strong>creas<strong>in</strong>gimportance <strong>of</strong> LTBI, disease <strong>in</strong> immigrant populati<strong>on</strong>s, groups at high risk (HIV-<strong>in</strong>fected, homeless <strong>and</strong>pris<strong>on</strong>ers) <strong>and</strong> importati<strong>on</strong> <strong>of</strong> drug resistance (e.g. multidrug-resistance from Eastern Europe <strong>and</strong> o<strong>the</strong>rcountries). In <strong>the</strong> United K<strong>in</strong>gdom, nati<strong>on</strong>al rates have rema<strong>in</strong>ed low overall but have gradually <strong>in</strong>creased <strong>in</strong>Engl<strong>and</strong> by 25% (1994-2004). 14 The L<strong>on</strong>d<strong>on</strong> regi<strong>on</strong> accounted for <strong>the</strong> highest proporti<strong>on</strong> <strong>of</strong> cases <strong>in</strong> 2007at 41% <strong>of</strong> all UK cases notified <strong>and</strong> had <strong>the</strong> highest TB notificati<strong>on</strong> rate at 44.8 per 100,000. Most TB casesc<strong>on</strong>t<strong>in</strong>ue to occur <strong>in</strong> young adults (61% were aged 15-44 years) <strong>and</strong> <strong>in</strong> <strong>the</strong> n<strong>on</strong>-UK born populati<strong>on</strong> (72%). 15In 2004, an acti<strong>on</strong> plan entitled ‘Stopp<strong>in</strong>g <strong>Tuberculosis</strong> <strong>in</strong> Engl<strong>and</strong>’ 16 was published by <strong>the</strong> UK Department<strong>of</strong> Health, to focus efforts <strong>on</strong> c<strong>on</strong>troll<strong>in</strong>g <strong>in</strong>creas<strong>in</strong>g TB levels.In 1996, a European network for surveillance (EuroTB) was <strong>in</strong>troduced, based <strong>on</strong> <strong>the</strong> participati<strong>on</strong> <strong>of</strong>nati<strong>on</strong>al TB surveillance <strong>in</strong>stituti<strong>on</strong>s <strong>in</strong> <strong>the</strong> 53 countries <strong>of</strong> <strong>the</strong> WHO European Regi<strong>on</strong>. Its aims were toimprove <strong>the</strong> c<strong>on</strong>tributi<strong>on</strong> <strong>of</strong> surveillance to TB c<strong>on</strong>trol <strong>in</strong> <strong>the</strong> WHO European regi<strong>on</strong>, through <strong>the</strong> provisi<strong>on</strong><strong>of</strong> valid, comparable epidemiological <strong>in</strong>formati<strong>on</strong> <strong>on</strong> TB. Annual reports <strong>in</strong>dicate that Cyprus had <strong>the</strong>lowest notificati<strong>on</strong> rate <strong>of</strong> disease <strong>in</strong> 2007 <strong>in</strong> <strong>the</strong> 27 EU countries (EU-27) at 5.3 cases per 100,000, whileIrel<strong>and</strong> ranked <strong>in</strong> sixteenth positi<strong>on</strong> (table 1.3).-2-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!